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Abstract
Objective—To examine black-white and Hispanic-white differences in total knee arthroplasty 
from 2001 to 2013 in a large cohort of patients diagnosed with osteoarthritis in the Veterans 
Affairs (VA) Healthcare System.
Methods—Data were from the VA Musculoskeletal Disorders Cohort, which includes data from 
electronic health records of over 5.4 million veterans with musculoskeletal disorders diagnoses. 
We included white (non-Hispanic), black (non-Hispanic), and Hispanic (any race) veterans age 50 
years or older with an osteoarthritis diagnosis from 2001-2011 (N=539,841). Veterans were 
followed from their first osteoarthritis diagnosis until September 30, 2013. As a proxy for 
increased clinical severity, analyses were also conducted for a sub-sample restricted to those who 
saw an orthopedic or rheumatology specialist (N=148,844). We used Cox proportional hazards 
regression to examine racial and ethnic differences in total knee arthroplasty by year of 
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osteoarthritis diagnosis, adjusting for age, sex, body mass index, physical and mental diagnoses, 
and pain intensity scores.
Results—We identified 12,087 total knee arthroplasty procedures in a sample of 473,170 white, 
50,172 black, and 16,499 Hispanic veterans. In adjusted models examining black-white and 
Hispanic-white differences by year of OA diagnosis, total knee arthroplasty rates were lower for 
black than for white veterans diagnosed in all but two years. There were no Hispanic-white 
differences regardless of when diagnosis occurred. These patterns held in the specialty clinic sub-
sample.
Conclusions—Black-white differences in total knee arthroplasty appear to be persistent in the 
VA, even after controlling for potential clinical confounders.
Knee osteoarthritis (OA) is one of the most common forms of arthritis and a significant 
source of disability.(1, 2) Total knee arthroplasty (TKA) is a well-established surgical 
treatment for advanced cases that can no longer be managed using more conservative 
treatments.(3) Despite the availability of this effective procedure, studies have documented 
lower rates of TKA among people of non-Hispanic black/African American race or Hispanic 
ethnicity than among non-Hispanic whites.(4-10) Studies of TKA rates over time show that, 
although overall use of TKA has increased across most racial and ethnic subgroups, rates 
among non-Hispanic black and Hispanic subgroups remain lower than among non-Hispanic 
whites.(6, 10-12)
Prior studies examining time trends in racial and ethnic differences in TKA have relied on 
cross-sectional comparisons of TKA procedure rates across racial and ethnic groups in the 
general population at different points in time.(6, 10-12) Cross-sectional studies of the 
general population do not take into account the slow, degenerative nature of OA and possible 
clinical and demographic differences across racial and ethnic groups that may impact 
clinical need for the procedure. Most prior studies have also relied on publicly available data 
from non-federal hospitals, thereby excluding patients served by the largest integrated 
healthcare system in the United States, the Veterans Affairs (VA) Healthcare System.(5, 6, 
10, 12, 13)
To address these gaps in the literature, we identified a large cohort of veterans who were 
diagnosed with OA while receiving care in the VA from 2001-2011. We followed this cohort 
through September 30, 2013 to determine if racial or ethnic differences in receipt of TKA 
have varied over time. We focused specifically on black-white and Hispanic-white 
differences, as blacks and Hispanics are the two largest minority groups in the VA patient 
population and Hispanic-white differences in TKA have not previously been examined in the 
VA. Our study further improves upon prior studies by adjusting for demographic and clinical 
factors (e.g., age, sex, pain intensity ratings, comorbid conditions) that may impact 
appropriateness of TKA and account for racial and ethnic differences in TKA. To focus the 
analysis on those who are most likely to be appropriate candidates for TKA, we also 
conducted sensitivity analyses restricted to a specialty clinic sub-sample of patients who had 
visited either an orthopedist or rheumatologist during the observation period, as patients 
with more advanced OA are often seen by these specialists prior to undergoing TKA.
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Methods
Data for this study were from the VA Musculoskeletal Disorders (MSD) Cohort, a 
comprehensive registry of all veterans with MSD diagnoses who received care in a VA 
inpatient and/or outpatient medical facility between 2000 and 2013.(14) To be eligible for 
the MSD Cohort, a veteran had to have an International Classification of Diseases, 9th 
Revision, Clinical Modification (ICD-9CM) code consistent with 1 of 1,685 distinct MSD 
diagnoses. The MSD index date was determined by the date of the first inpatient MSD code 
or the date of an initial outpatient code in the observation period for which there is a second 
confirmatory outpatient code in the following 18 months. Additional demographic and 
clinical information was extracted from VA electronic clinical and administrative data 
sources in the VA Corporate Data Warehouse for all eligible veterans both prior to and 
following the date of their first MSD diagnosis to enable the longitudinal analysis of 
numerous pain treatments and outcomes. The VA Connecticut Healthcare System 
Institutional Review Board approved the MSD Cohort and the analyses reported here prior 
to data collection.
For the current analysis, we focused on veterans who entered the MSD Cohort with OA 
between 2001 and 2011. We focused on these years because we were interested in following 
veterans with new OA diagnoses (by excluding veterans who entered the MSD cohort in 
2000) and to allow at least a 2-year follow up period (by excluding veterans who entered in 
2012 or 2013). We included veterans with any OA diagnosis (ICD-9CM=715.xx) recorded at 
≥2 outpatient visits within 18 months of one another or ≥1 inpatient stay in the observation 
period. The date of the first OA diagnosis in the years 2001 to 2011 was used as the index 
date. We excluded those who had TKA in one or both knees on or before their first OA 
diagnosis within the study timeframe. Because we were interested in TKA utilization as an 
elective treatment for OA, we also excluded veterans who had a diagnosis of rheumatoid 
arthritis (ICD-9 714.xx) or were less than 50 years old, as TKA is often not recommended 
for younger patients given the longevity of the prosthesis. We further excluded veterans who 
had a racial/ethnic classification other than non-Hispanic white, non-Hispanic black, or 
Hispanic or were missing racial/ethnic information. Veterans who met these criteria were 
followed from their OA index date until receipt of TKA, death (from the VA Beneficiary 
Identification Records Locator Subsystem), or September 30, 2013, whichever came first.
Veterans who met the previous criteria were included in the main analyses, with each 
veteran being counted only one time and tracked from their OA index date. We also 
conducted subgroup analyses in which we further restricted the analytic sample to veterans 
who met all eligibility criteria and had one or more visits to either an orthopedist or 
rheumatologist (VA clinic codes 409 and 314, respectively) after their first OA diagnosis but 
on or prior to the date of TKA. The purpose of this analysis was to determine whether racial 
and ethnic differences in TKA occur among patients with more advanced OA, as patients 
with OA are typically referred to an orthopedist or rheumatologist once their OA has 
progressed to the point when it can no longer be treated adequately in primary care. The 
specialty clinic subgroup analysis also would indicate whether racial or ethnic differences 
observed in the full OA sample could be due to differential referral to or use of specialists.
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Primary Predictor: Race/Ethnicity
In the VA, self-identified race and ethnicity is collected from veterans at the time they enroll 
for services and may be updated at every clinical encounter. Veterans are permitted to 
specify multiple races as well as indicate whether they are of Hispanic or Latino ethnicity. 
For this study, we used the latest available non-missing race and ethnicity recorded in each 
veteran's VA administrative record. We filled in missing values with the most recent race and 
ethnicity data from the Centers for Medicare and Medicaid Services Master Beneficiary 
Summary File whenever possible, which resulted in relatively few veterans being excluded 
due to missing race/ethnicity (n=10,163, 1.6%). We categorized veterans with non-missing 
racial/ethnic information into three mutually-exclusive groups for analyses: non-Hispanic 
white (i.e., whites), non-Hispanic black (i.e., black), or Hispanic ethnicity. In accordance 
with the latest standards for classification of federal data on race and ethnicity (15), veterans 
of Hispanic ethnicity were categorized as Hispanic regardless of whether they were also 
identified as white, black, or another race.
Covariates
Covariates included age, sex, and pain intensity scores on the OA index date. Pain intensity 
was assessed using the pain intensity numeric rating scale (NRS) score from the VA Vital 
Signs data.(16, 17) The NRS is used in routine clinical care to screen for pain by asking the 
patient, “On a scale of 0 to 10, where 0 means no pain and 10 means the worst possible pain, 
what is your current pain level?” Using the highest NRS score recorded on the day of OA 
diagnosis, we categorized pain intensity into four levels: 0, no pain; 1 to 3, mild; 4 to 6, 
moderate; and 7 or greater, severe.(18, 19) Body mass index (BMI) was calculated from the 
height and weight recorded on the OA index date or, if not recorded on the index date, based 
on those measures recorded within the prior 12 months or up to six months after.
We also identified comorbid diagnoses concurrent with the OA index diagnosis. Specifically, 
concurrent conditions were those that occurred within the prior 12 months or up to six 
months after the index OA diagnosis; these conditions also required 2 outpatient codes 
within 18 months of one another or 1 inpatient code. We controlled for overall clinical 
severity by calculating the Charlson Comorbidity Index (CCI), with higher scores indicating 
greater comorbidity.(20, 21) We also included four mental health diagnoses that are not 
included in the CCI: depressive disorder, alcohol use disorder, drug use disorder, and post-
traumatic stress disorder (PTSD) (see eTable 1 for ICD-9CM codes). We controlled for these 
conditions because they have high prevalence among veterans, may vary across race and 
ethnicity, and may be viewed as contraindications for TKA.(22, 23)
Outcome: Receipt of TKA
Our study outcome was receipt of TKA within a VA facility, defined using Current 
Procedural Terminology (CPT) and ICD-9CM procedure codes (CPT 27447 or ICD-9CM 
81.54).
Statistical Analyses
Descriptive statistics for all clinical and demographic characteristics by racial/ethnic 
category were compared using Analyses of Variance (ANOVA) for continuous variables and 
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a χ2 test or Fisher exact test for categorical variables. We used Cox proportional hazards 
regression to examine racial and ethnic differences in the rate of TKA by the year of OA 
diagnosis, after adjusting for age, sex, CCI, depression, alcohol use disorder, drug use 
disorder, PTSD, BMI, and pain intensity. We conducted all analyses in the full analytic 
sample and in the specialty clinic sub-sample. Veterans who died or did not have TKA by 
September 30, 2013 were censored in these analyses.
Because excluding cases with missing values may bias results,(24) missing values on BMI 
(n=15,552, 2.9%) and pain intensity NRS scores (n=63,243, 11.7%) were imputed by 
multiple imputation using the SAS MI procedure (SAS 9.4, Cary, NC). The imputation 
model included race/ethnicity, age at OA diagnosis, year of OA diagnosis, CCI, and whether 
or not the patient received TKA. Five datasets were imputed and the PROC MIANALYSE 
procedure in SAS was used to combine the hazard ratio estimates according to Rubin's rules.
(25) We conducted a sensitivity analysis comparing the results of a complete case analysis 
with the results using the imputed data and found that results were substantively the same. 
We chose to report results from multivariable models based on imputed data. All analyses 
were conducted using SAS 9.4 (SAS, Cary, NC).
Role of funding source
This work was funded by the Veterans Health Administration. The funding source had no 
involvement in the design or conduct of the study.
Results
Sample Characteristics
A total of 539,841 veterans (10.0%) in the MSD Cohort met the inclusion criteria for this 
analysis (Figure 1). Of those, 148,844 (27.6%) had a visit with an orthopedic surgeon or 
rheumatologist and were included in sensitivity analyses restricted to the specialty clinic 
sub-sample. For the racial and ethnic comparisons, 473,170 (87.6%) veterans were 
categorized as non-Hispanic white, 50,172 (9.3%) as non-Hispanic black, and 16,499 (3.1%) 
as Hispanic. Among those included in the Hispanic category, 13% had no other racial or 
ethnic classification on file, 78% had a white race classification on file, and 5% had a black 
race classification on file. There were significant differences in all demographic and clinical 
characteristics across the three racial and ethnic groups (Table 1). Compared to white 
veterans, black and Hispanic veterans were younger; more likely to have CCI scores ≥3; and 
more likely to have depression, PTSD, and alcohol use diagnoses. Compared to whites or 
Hispanics, blacks were more likely to be female, have drug use diagnoses, and report severe 
pain intensity, and were less likely to be overweight or obese (defined as BMI >25). Similar 
racial and ethnic differences were observed within the specialty clinic sub-sample, although 
this group included higher percentages of veterans who were black or Hispanic, younger, 
female, obese, and had more mental health diagnoses than the full sample (Table 1). Pain 
intensity ratings were also higher in the specialty clinic sub-sample than in the full analytic 
sample (Table 1).
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Predictors of TKA in the Full Analytic Sample
We identified 12,087 TKA procedures during a median follow-up period of 8 years, for an 
overall rate of 2.2%. In a model examining racial and ethnic differences by year of OA 
diagnosis and adjusting for age, sex, comorbidity, BMI, and pain intensity, blacks were less 
likely than whites to undergo TKA for those diagnosed in all but two years of the 
observation period (see Figure 2 for year-specific black-white and Hispanic-white hazard 
ratios; see eTable 2 for full model results). Likelihood of undergoing TKA was not 
significantly different between Hispanics and whites for those diagnosed in any of the years 
of observation (Figure 2; eTable 2). As shown in Figure 3, likelihood of undergoing TKA 
decreased as age and CCI scores increased and was significantly lower among those with 
PTSD. In contrast, likelihood of undergoing TKA increased as BMI and pain intensity 
increased.
Racial and Ethnic Differences in TKA in the Specialty Clinic Sub-sample
In analyses restricted to the specialty clinic sub-sample, there were 12,025 TKA procedures 
performed, for an overall rate of 8.1%. Patterns of racial and ethnic differences in the 
adjusted models were similar to those observed in the full analytic sample, in that blacks 
were less likely than whites to undergo TKA for those diagnosed in all but two years of the 
observation period and there were no Hispanic-white differences among those diagnosed in 
any years (Figure 2 and eTable 2).
Discussion
In this longitudinal analysis of a large national cohort of veterans, we found lower likelihood 
of TKA for blacks than for whites diagnosed with OA in most years from 2001 to 2011. In 
contrast, we found no difference in the likelihood of TKA between Hispanics and whites 
diagnosed in any year. These patterns were observed after controlling for racial and ethnic 
differences in demographic and clinical characteristics that could confound the association 
between race/ethnicity and receipt of TKA, including age, sex, physical and mental 
comorbidities, BMI, and pain intensity. The TKA patterns also persisted among the sub-
sample of veterans who had consulted with an orthopedic surgeon or rheumatologist. The 
consistent pattern of black-white differences in receipt of TKA in the overall sample of 
veterans with OA and in the specialty clinic sub-sample suggest that the observed racial 
differences were not due to differences in clinical severity, as most patients with OA are not 
seen in these specialty clinics until their disease has advanced beyond what can be 
adequately managed in primary care. It is important to note that, not only were pain intensity 
ratings higher across all racial and ethnic groups in the specialty clinic sub-sample, the 
percentages of black and Hispanic veterans in the sub-sample were also slightly higher than 
in the overall sample with OA. The latter finding suggests that systematic differences in 
referral to, or use of, these specialists are unlikely to explain the black-white differences in 
TKA we observed in this VA cohort.
Our study builds upon previous work documenting lower rates of TKA in black veterans 
with OA compared to their white counterparts.(26) Not only do we replicate previous 
findings in a more comprehensive national cohort of veterans over a longer time frame, we 
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demonstrate that the black-white difference in receipt of TKA has persisted in recent years. 
The black-white differences in TKA observed among veterans is similar to patterns found in 
studies showing that racial differences in TKA have persisted or increased over time outside 
the VA Healthcare System.(6, 10, 11) However, the VA is a unique setting in which to 
examine potential disparities because it is an integrated healthcare system where all patients 
must meet certain eligibility requirements to gain access and, once enrolled, have similar 
access to services. Our findings therefore provide strong support for the conclusion that 
lower utilization of TKA among blacks cannot be fully explained by differences in 
healthcare access.
Identifying why black-white differences in TKA persist in the VA remains a challenge. The 
differences are not likely due to differences in clinical need, as all patients included in the 
analyses had a diagnosis of OA. Additionally, we controlled for pain intensity at the time of 
diagnosis, which was higher among blacks and was an independent predictor of receipt of 
TKA. Differences in access to the procedure likely do not explain our finding, as all patients 
were receiving care in the VA Healthcare System. However, we might consider whether 
black veterans are disproportionately served in VA facilities with lower volumes of TKA 
procedures, overall. Another possible factor that has not been examined is whether there are 
racial differences in the opportunity costs of having surgery (e.g., time off work, etc.) or the 
availability of social support during the recovery period.
There is considerable evidence that much of the black-white difference in receipt of TKA is 
driven by differences in patient preferences for arthritis treatments.(27-30) Compared to 
whites, blacks are less willing to consider joint replacement as a treatment option for 
arthritis, and are more willing to seek out non-invasive treatment or coping strategies such as 
physical therapy, massage therapy, or prayer.(29, 31, 32) While we were unable to ascertain 
treatment preferences using the data available for this study, our findings of persistently 
lower rates of TKA among black veterans with OA are consistent with this explanation.
This is the first study to examine Hispanic-white differences in TKA within the VA. In 
contrast to some studies in non-veteran populations,(4, 6, 11) we observed no Hispanic-
white differences in receipt of TKA among veterans. One possible reason that we did not 
find significant ethnic differences could be the relatively low number of Hispanics in our 
cohort. Due to citizenship and education requirements for military service, it is also possible 
that there are fewer differences between Hispanic and non-Hispanic white veterans than 
between Hispanic and non-Hispanic white patients in the civilian population. Future work is 
needed to determine whether differences between Hispanic veterans and civilians in 
characteristics such as acculturation, language, and socioeconomic status account for smaller 
Hispanic-white differences across VA and non-VA healthcare settings.
This study contributes to a large literature on racial and ethnic differences in the prevalence, 
impact, and treatment of OA, with a specific focus on long-standing differences in receipt of 
TKA.(33-38) In the 3-generation framework of health disparities research,(39) this is a first 
generation study that documents a persistent black-white difference in receipt of TKA 
among veterans. An abundance of second-generation studies have attempted to determine 
factors that explain lower use of TKA among black patients (e.g., patient preferences) within 
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and outside the VA setting,(27, 29, 30, 33, 36, 37, 40-44) and a handful of studies have 
tested interventions to reduce the difference in receipt of TKA, with limited success.(45-48) 
Our study underscores the need to continue monitoring and working to reduce racial and 
ethnic differences in TKA, as black-white differences persist despite targeted efforts to 
reduce racial differences in this procedure.
Given the persistence of black-white differences in TKA, it may be appropriate to take steps 
to ensure the pain management needs of black veterans with OA are being met, independent 
of whether patients receive TKA. For example, we observed higher pain intensity ratings 
among black patients. To meet the needs of all veterans with OA, it may be necessary to 
pursue less invasive and/or complementary pain management strategies that preserve 
function for as long as possible, while continuing to develop interventions reduce black-
white differences in receipt of TKA.
Limitations
Conclusions based on this study should be considered in light of limitations that are inherent 
in the VA administrative data upon which it was based. Our use of race and ethnicity 
documented in administrative records may have resulted in some misclassification of 
veterans into the three racial and ethnic groups compared in this study. We were also unable 
to examine TKA separately for subgroups of Hispanic veterans who had an additional 
minority race classification on file due to the small number of people in those groups. 
Because eligibility was based on diagnoses of general OA in VA electronic health records, 
our cohort is an approximation of the true population of Veterans with knee OA, and our OA 
index date may not represent the initial onset of OA for all veterans in the analysis. We used 
all OA diagnostic codes, rather than restricting diagnoses to those indicative of knee OA, 
because the specific joint affected by OA is often not reflected in the diagnostic code applied 
to a visit. This is particularly problematic for knee OA because the ICD-9CM system that 
was in effect during the study timeframe did not include a specific code for knee OA. Under 
the ICD-9CM system, diagnoses of knee OA could be recorded using general OA codes or 
conditions specific to regions close to the knee (e.g., lower extremity, hip, foot/ankle). Given 
the uncertainty regarding how specific ICD-9CM codes were applied to cases of knee OA, 
we chose to include in our cohort patients with any OA diagnoses. This decision may have 
resulted in patients with OA in other regions of the body being included in our analyses.
While it would have been ideal to use the strict criteria for knee OA established by American 
College of Rheumatology to determine specific diagnoses or disease severity based on 
radiological assessment, this was not feasible given the size of the VA patient population or 
the data available. Because we did not have access to non-VA medical records, we also could 
not determine whether veterans in our analysis were being treated for OA outside the VA 
prior to or after receiving a diagnosis of OA within the VA. Although we attempted to 
approximate severity of OA using two variables that were available to us (i.e., pain intensity 
ratings and being seen by an orthopedist or rheumatologist), we recognize that both variables 
are limited in that we were unable to determine whether they were directly linked to OA, as 
opposed to other conditions. Despite these limitations, this work fills important gaps in 
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knowledge regarding changes in racial and ethnic differences in TKA use among veterans 
over time.
Conclusions
In the VA Healthcare System, black veterans diagnosed with OA in most years from 2001 to 
2011 were less likely to undergo TKA than white veterans by 2013 after adjusting for 
demographic and key clinical characteristics. In contrast, Hispanics and whites received 
TKA at similar rates across all years. To ensure that the health care needs of all veterans are 
being met, it is important to continue efforts to understand and develop interventions to 
reduce racial differences in TKA in veterans.
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Significance and Innovations
- To date, this is the largest study of racial and ethnic differences in total knee 
arthroplasty in the Veterans Affairs (VA) Healthcare System, including all 
veterans diagnosed with osteoarthritis in the VA from 2001 to 2011.
- This is the first study to examine Hispanic-white differences in total knee 
arthroplasty within the VA.
- The large study population, long follow-up period, and availability of 
demographic and clinical information in VA electronic health records make it 
possible to examine whether racial and ethnic differences in total knee 
arthroplasty vary across year of initial osteoarthritis diagnosis after 
controlling for confounders such as age and pain intensity.
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Figure 1. 
Identification of the Full and Sub-group Analytic Samples. The analyses included veterans 
who entered the Musculoskeletal Disorders Cohort between 2001 and 2011 with a 
qualifying diagnosis of osteoarthritis. Veterans were excluded if they had rheumatoid 
arthritis, were less than 50 years old, had already had total knee arthroplasty, or who had a 
racial/ethnic classification other than non-Hispanic white, non-Hispanic black, or Hispanic 
or were missing racial/ethnic information. We conducted sensitivity analyses in a subsample 
restricted to those who had one or more visits to an orthopedist or rheumatologist.
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Figure 2. 
Racial and Ethnic Differences in Total Knee Arthroplasty by Year of Osteoarthritis 
Diagnosis.
Black-white and Hispanic-white hazard ratios for undergoing total knee arthroplasty by 
September 30, 2013, plotted by year of osteoarthritis diagnosis. Specialty clinic sub-sample 
included those who consulted with an orthopedic surgeon or rheumatologist within the study 
timeframe. Models adjusted for age, sex, Charlson Comorbidity Index, body mass index, 
pain severity, and diagnoses of depression, alcohol use disorder, drug use disorder, and post-
traumatic stress disorder.
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Figure 3. 
Predictors of Total Knee Arthroplasty Other than Race/Ethnicity.
Estimates are from analyses conducted on the full analytic sample. Models included all 
covariates plus indicators for black race, Hispanic ethnicity, year of osteoarthritis diagnosis, 
and all race/ethnicity by year interactions (see eTable 2 for full model results).
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